Skip to main content
Umamaheswar Duvvuri, MD, Otolaryngology (ENT), New York, NY

Umamaheswar Duvvuri MD


Mendik Foundation Professor and Chair Department of Otolaryngology; NYU Grossman School of Medicine & NYU Langone Health

Join to View Full Profile
  • 555 1st AveSuite 801bNew York, NY 10003

  • Phone+1 412-647-2100

Dr. Duvvuri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UPMC Medical Education (Pittsburgh)
    UPMC Medical Education (Pittsburgh)Residency, Otolaryngology - Head and Neck Surgery, 2003 - 2007
  • UPMC Medical Education
    UPMC Medical EducationInternship, Transitional Year, 2002 - 2003
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2002

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2002 - 2026
  • NY State Medical License
    NY State Medical License 2023 - 2025
  • Otolaryngology
    American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons
  • Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Publications & Presentations

PubMed

Journal Articles

  • Transoral Robotic Surgery and the Unknown Primary  
    Umamaheswar Duvvuri, MD, ORL
  • Transoral Surgery Using the Flex Robotic System: Initial Experience in the United States  
    Neerav Goyal, Mohamad Issa, David Goldenberg, Michael J Persky, Umamaheswar Duvvuri, Head & Neck

Press Mentions

  • Dysfunctional B Cells: New Cancer Immunotherapy Target
    Dysfunctional B Cells: New Cancer Immunotherapy TargetFebruary 20th, 2025
  • Scientists Identify a New Cancer Immunotherapy Target: Dysfunctional B Cells
    Scientists Identify a New Cancer Immunotherapy Target: Dysfunctional B CellsFebruary 19th, 2025
  • How Malaria Drugs Could Play a Part in Treating Chemotherapy-Resistant Head and Neck Cancers
    How Malaria Drugs Could Play a Part in Treating Chemotherapy-Resistant Head and Neck CancersMarch 28th, 2022
  • Join now to see all

Grant Support

  • Novel Targets to Treat Head & Neck Cancer in VeteransVA MEDICAL CENTER2021–2025
  • Novel Targets to Treat Head & Neck Cancer in VeteransVA MEDICAL CENTER2021–2025
  • Novel Targets to Treat Head & Neck Cancer in VeteransVETERANS HEALTH ADMINISTRATION2021–2025
  • Novel Targets to Treat Head & Neck Cancer in VeteransVETERANS HEALTH ADMINISTRATION2021–2025
  • Inhibition of lysosomal flux in carcinogen-induced head and neck cancerNEW YORK UNIVERSITY SCHOOL OF MEDICINE2019–2024
  • Inhibition of lysosomal flux in carcinogen-induced head and neck cancerNEW YORK UNIVERSITY SCHOOL OF MEDICINE2019–2024
  • Inhibition of lysosomal flux in carcinogen-induced head and neck cancerNEW YORK UNIVERSITY SCHOOL OF MEDICINE2019–2024
  • Imaging Of Articular Cartilage For OsteoarthrNational Center For Research Resources2000–2002
  • Quantification Of Gene Expression W/ Labeled Antibodies: Gene Ther, HIV VaccineNational Center For Research Resources1997

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: